ALC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Alcon AG is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The business has solid fundamentals and improving revenue growth, but the stock’s technical trend is still weak and the options market is leaning bearish. Since the user is impatient and does not want to wait for an optimal entry, I would still not buy aggressively at current levels. My direct view: hold, not buy.
ALC is currently trading around 74.27 after a 2.83% regular-session gain, but the broader technical setup remains bearish. MACD histogram is negative at -0.427, RSI_6 is neutral at 40.56, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price is sitting near support at 73.35 and below the pivot at 77.15, which suggests the rebound has not yet confirmed a durable uptrend. Short-term pattern data also points to weak follow-through, with expectations of roughly -0.46% next day and -2.99% next week.
["Revenue in 2025/Q4 increased 8.63% year over year to 2.718B, showing healthy top-line growth.", "Gross margin improved sharply to 61.11%, which supports better operational quality.", "Wells Fargo upgraded the stock to Overweight with a $97 target, citing new product cycles and improving 2026 growth.", "BTIG remains Buy-rated with an $87 target, highlighting solid Q4 results, product cadence, strong free cash flow, and M&A/share buyback optionality.", "Hedge funds are buying, with buying activity up 470.5% last quarter."]
["Net income fell 23.59% year over year in the latest quarter.", "EPS declined 22.81% year over year, showing profit pressure despite sales growth.", "Technical trend is bearish, with MACD below zero and moving averages stacked bearishly.", "Options flow is tilted bearish with put-heavy ratios.", "Congress trading data shows 1 sale and 0 purchases in the last 90 days, suggesting caution.", "There is no AI Stock Picker signal and no recent SwingMax buy signal."]
In 2025/Q4, Alcon delivered solid revenue growth, with sales up 8.63% year over year to 2.718B. However, profitability weakened: net income dropped 23.59% and EPS fell 22.81% year over year. The positive offset is that gross margin expanded to 61.11%, up 10.39% year over year, which suggests better product mix or operating efficiency. Overall, the latest quarter shows good top-line momentum but weaker bottom-line performance.
Analyst sentiment is mixed but improving. Recent action includes Wells Fargo upgrading Alcon to Overweight with a $97 target, BTIG maintaining Buy and lifting its target to $87, while Stifel keeps Hold with an $82 target and Barclays keeps Equal Weight with a $90 target. The trend is that target prices have generally moved higher after Q4, but the Street is still split rather than uniformly bullish. Wall Street pros see strengths in new product launches, innovation, cash flow, and growth potential, while the cautious camp focuses on valuation, incomplete upside confirmation, and only moderate near-term estimate support.
